Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cells-Reference-Cited by-同舟云学术

Dasatinib (BMS-35482) has synergistic activity with paclitaxel and carboplatin in ovarian cancer cells

Published:2011-04 Issue:1 Volume:121 Page:187-192
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Teoh Deanna,Ayeni Tina A.,Rubatt Jennifer M.,Adams David J.,Grace Lisa,Starr Mark D.,Barry William T.,Berchuck Andrew,Murphy Susan K.,Secord Angeles Alvarez

Funder

National Cancer Institute

Bristol-Myers-Squibb

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference20 articles.

1. Cancer statistics, 2009;Jemal;CA Cancer J Clin,2009

2. Identification and validation of phospho-Src, a novel and potential pharmacodynamic biomarker for dasatinib, a multi-targeted kinase inhibitor;Luo;Cancer Chemother Pharmacol,2008

3. Activity of pp 60c-Src in 60 different cell lines derived from human tumors;Budde;Cancer Biochem Biophys,1994

4. Activated Src protein tyrosine kinase is overexpressed in late-stage human ovarian cancers;Wiener;Gynecol Oncol,2003

5. An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer;Dressman;J Clin Oncol,2007

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging green synthetic routes for thiazole and its derivatives: Current perspectives;Archiv der Pharmazie;2023-11-27

2. Adverse Toxic Effects of Tyrosine Kinase Inhibitors on Non-Target Zebrafish Liver (ZFL) Cells;International Journal of Molecular Sciences;2023-02-15

3. Brønsted acid-promoted ring-opening and annulation of thioamides and 2H-azirines to synthesize 2,4,5-trisubstituted thiazoles;Organic & Biomolecular Chemistry;2023

4. Src inhibitor dasatinib sensitized gastric cancer cells to cisplatin;Medical Oncology;2022-12-16

5. Novel Approaches for the Solid-Phase Synthesis of Dihydroquinazoline-2(1H)-One Derivatives and Biological Evaluation as Potential Anticancer Agents;Molecules;2022-12-05